• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肝病患者尿液中异常三羟基胆汁酸含量稀少。

A paucity of unusual trihydroxy bile acids in the urine of patients with severe liver diseases.

作者信息

Nakashima T, Sakamoto Y, Inaba K, Mitsuyoshi H, Ishikawa H, Nakajima Y, Sakai M, Shima T, Kashima K

机构信息

Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto,

出版信息

Hepatology. 1999 May;29(5):1518-22. doi: 10.1002/hep.510290502.

DOI:10.1002/hep.510290502
PMID:10216137
Abstract

To clarify the relationship between the occurrence of unusual trihydroxy bile acids, namely hyocholic acid, ursocholic acid (UCA), and omega-muricholic acid (omega-MCA) in urine and liver disease severity, urinary bile acids were analyzed by gas-liquid chromatography in acute and late phases of acute hepatitis and before and after ursodeoxycholic acid (UDCA) loading in healthy adults and liver cirrhosis patients. In 11 patients with acute hepatitis, the occurrence rates and amounts of unusual trihydroxy bile acids were increased in the late (recovery) phase, as compared with those in the early phase. In 10 patients with severe acute hepatitis who had prothrombin times exceeding 16 seconds, these bile acids had completely disappeared from the urine in the early phase but reappeared in the late phase in those who had a good outcome, though never in a patient who died. After UDCA administration for a week, the amounts of unusual bile acids, especially UCA and omega-MCA, which are thought to be synthesized through 12 alpha- and 6 alpha-hydroxylations, respectively, from UDCA, were clearly increased in 10 healthy adults but only slightly changed in 10 patients with liver cirrhosis. In conclusion, hepatic hydroxylations of dihydroxy bile acids as a detoxification reaction were impaired in severe liver diseases, which may play a role in the intensification and perpetuation of hepatocellular injuries.

摘要

为阐明尿液中异常三羟基胆汁酸(即猪胆酸、熊去氧胆酸(UCA)和ω-鼠胆酸(ω-MCA))的出现与肝脏疾病严重程度之间的关系,我们采用气液色谱法对急性肝炎急性期和后期、健康成年人及肝硬化患者服用熊去氧胆酸(UDCA)前后的尿胆汁酸进行了分析。在11例急性肝炎患者中,与早期相比,异常三羟基胆汁酸的发生率和含量在后期(恢复期)有所增加。在10例凝血酶原时间超过16秒的重症急性肝炎患者中,这些胆汁酸在早期从尿液中完全消失,但在预后良好的患者后期再次出现,而死亡患者则从未出现。在10名健康成年人中,服用UDCA一周后,异常胆汁酸的含量,尤其是被认为分别通过UDCA的12α-和6α-羟基化合成的UCA和ω-MCA,明显增加,而在10例肝硬化患者中仅略有变化。总之,在严重肝脏疾病中,作为解毒反应的二羟基胆汁酸的肝脏羟基化受损,这可能在肝细胞损伤的加重和持续中起作用。

相似文献

1
A paucity of unusual trihydroxy bile acids in the urine of patients with severe liver diseases.重症肝病患者尿液中异常三羟基胆汁酸含量稀少。
Hepatology. 1999 May;29(5):1518-22. doi: 10.1002/hep.510290502.
2
Unusual trihydroxylated bile acids in urine of patients with liver cirrhosis.肝硬化患者尿液中异常的三羟基化胆汁酸。
Clin Chim Acta. 1983 Jan 7;127(1):61-7. doi: 10.1016/0009-8981(83)90075-x.
3
Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis.接受鹅去氧胆酸、熊去氧胆酸或利福平治疗的患者以及肝硬化患者尿液中的异常三羟基胆汁酸。
Hepatology. 1990 Feb;11(2):255-60. doi: 10.1002/hep.1840110215.
4
Unusual trihydroxy bile acids in the urine of healthy humans.健康人尿液中的异常三羟基胆汁酸。
Clin Chim Acta. 1986 Oct 15;160(1):47-53. doi: 10.1016/0009-8981(86)90334-7.
5
Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.熊去氧胆酸治疗后慢性肝病患者血清和尿液中硫酸化熊去氧胆酸增加。
J Gastroenterol Hepatol. 1996 Apr;11(4):385-90. doi: 10.1111/j.1440-1746.1996.tb01388.x.
6
Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.熊去氧胆酸,一种亲水性胆汁酸,在原发性胆汁性肝硬化中未能改善肝功能参数:与熊脱氧胆酸的比较。
Am J Gastroenterol. 1997 Jun;92(6):1035-7.
7
Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.肝胆疾病患者尿液、血清和胆汁中的硫酸化及非硫酸化胆汁酸。
Gastroenterology. 1975 Mar;68(3):545-53.
8
Altered bile acid metabolism in liver disease: concurrent occurrence of C-1 and C-6 hydroxylated bile acid metabolites and their preferential excretion into urine.肝病中胆汁酸代谢的改变:C-1和C-6羟基化胆汁酸代谢产物的同时出现及其优先排泄到尿液中。
J Lipid Res. 1990 Feb;31(2):249-59.
9
Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.原发性胆汁性肝硬化患者胆汁酸与血清胆汁酸的关系及对熊去氧胆酸的反应
Am J Gastroenterol. 1998 Sep;93(9):1498-504. doi: 10.1111/j.1572-0241.1998.00470.x.
10
Concurrent occurrence of 3 beta,12 alpha-dihydroxy-5-cholenoic acid associated with 3 beta-hydroxy-5-cholenoic acid and their preferential urinary excretion in liver diseases.3β,12α-二羟基-5-胆甾烯酸与3β-羟基-5-胆甾烯酸的同时出现及其在肝脏疾病中的优先尿排泄
J Lipid Res. 1989 Aug;30(8):1233-42.

引用本文的文献

1
Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method.采用 UPLC-MRM-MS 验证方法对人、鼠和大鼠的循环和胆汁酸进行靶向分析。
J Lipid Res. 2012 Oct;53(10):2231-2241. doi: 10.1194/jlr.D028803. Epub 2012 Jul 19.